WallStreetZenWallStreetZen

NYSE: ZBH
Zimmer Biomet Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZBH

Based on 10 analysts offering 12 month price targets for Zimmer Biomet Holdings Inc.
Min Forecast
$125.00+3.49%
Avg Forecast
$133.20+10.28%
Max Forecast
$140.00+15.91%

Should I buy or sell ZBH stock?

Based on 10 analysts offering ratings for Zimmer Biomet Holdings Inc.
Hold
Strong Buy
0 analysts 0%
Buy
3 analysts 30%
Hold
6 analysts 60%
Sell
0 analysts 0%
Strong Sell
1 analysts 10%

Be the first to know when Wall Street analysts revise their ZBH stock forecasts and price targets.

ZBH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-02-12
lockedlocked$00.00+00.00%2024-02-09
JP Morgan
Top 17%
84
HoldMaintains$125.00+3.49%2024-02-09
RBC Capital
Bottom 10%
10
BuyReiterates$140.00+15.91%2024-02-09
Raymond James
Top 16%
85
BuyMaintains$137.00+13.43%2024-01-03
Morgan Stanley
Bottom 16%
16
HoldMaintains$125.00+3.49%2023-12-04
JMP Securities
Bottom 4%
4
BuyMaintains$140.00+15.91%2023-11-13

1 of 1

Forecast return on equity

Is ZBH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is ZBH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ZBH revenue forecast

What is ZBH's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$7.8B+4.89%
Avg 2 year Forecast
$8.1B+9.75%
Avg 3 year Forecast
$8.5B+14.29%
ZBH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZBH earnings growth forecast

How is ZBH forecast to perform vs Medical Devices companies and vs the US market?
Company
22.7%
Industry
25.2%
Market
21.77%
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ZBH revenue growth forecast

How is ZBH forecast to perform vs Medical Devices companies and vs the US market?
Company
4.58%
Industry
8.27%
Market
10.1%
ZBH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZBH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZBH vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ZBH$120.78$133.20+10.28%Hold
ALGN$300.82$331.33+10.14%Buy
STE$200.90$239.60+19.26%Buy
PHG$20.61N/AN/A
SWAV$328.60$313.71-4.53%Buy
View Top Medical Device Stocks

Zimmer Biomet Holdings Stock Forecast FAQ

Is Zimmer Biomet Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: ZBH) stock is to Hold ZBH stock.

Out of 10 analysts, 0 (0%) are recommending ZBH as a Strong Buy, 3 (30%) are recommending ZBH as a Buy, 6 (60%) are recommending ZBH as a Hold, 0 (0%) are recommending ZBH as a Sell, and 1 (10%) are recommending ZBH as a Strong Sell.

If you're new to stock investing, here's how to buy Zimmer Biomet Holdings stock.

What is ZBH's revenue growth forecast for 2024-2026?

(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 4.58% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Zimmer Biomet Holdings's revenue in 2024 is $7,394,200,000.On average, 11 Wall Street analysts forecast ZBH's revenue for 2024 to be $1,590,525,030,941, with the lowest ZBH revenue forecast at $1,586,324,910,170, and the highest ZBH revenue forecast at $1,593,666,918,158. On average, 11 Wall Street analysts forecast ZBH's revenue for 2025 to be $1,664,310,160,376, with the lowest ZBH revenue forecast at $1,655,028,057,540, and the highest ZBH revenue forecast at $1,678,120,518,417.

In 2026, ZBH is forecast to generate $1,733,102,314,211 in revenue, with the lowest revenue forecast at $1,720,665,403,865 and the highest revenue forecast at $1,747,315,867,440.

What is ZBH's forecast return on assets (ROA) for 2024-2027?

(NYSE: ZBH) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is ZBH's Price Target?

According to 10 Wall Street analysts that have issued a 1 year ZBH price target, the average ZBH price target is $133.20, with the highest ZBH stock price forecast at $140.00 and the lowest ZBH stock price forecast at $125.00.

On average, Wall Street analysts predict that Zimmer Biomet Holdings's share price could reach $133.20 by Apr 4, 2025. The average Zimmer Biomet Holdings stock price prediction forecasts a potential upside of 10.28% from the current ZBH share price of $120.78.

What is ZBH's forecast return on equity (ROE) for 2024-2027?

(NYSE: ZBH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.